| Wen-chih Hank Wu, MD | |
|
830 Chalkstone Ave, 111-a, Providence, RI 02908-4734 | |
| (401) 273-7100 | |
| (401) 457-3357 |
| Full Name | Wen-chih Hank Wu |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 29 Years |
| Location | 830 Chalkstone Ave, Providence, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700804192 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD 10730 (Rhode Island) | Primary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 037829 (Connecticut) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Miriam Hospital | Providence, RI | Hospital |
| Newport Hospital | Newport, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lifespan Physician Group Inc | 2567455082 | 631 |
News Archive
Regulus Therapeutics Inc. today announced that new data from its metabolic disease program were presented at the "Diabetes" Keystone Symposium held April 12-17 in Whistler, British Columbia. The new pre-clinical research findings showed that therapeutic oligonucleotides targeting microRNA are able to improve insulin resistance and normalize plasma glucose in mouse models of diabetes while having no significant effect on glucose or insulin levels in normal mice.
ClaimRemedi, a provider of claim lifecycle management solutions, announced recently that they have signed an agreement with HealthPac Computer Systems, Inc., a Savannah, GA based Practice Management and Medical Billing software company. Under the agreement, ClaimRemedi will provide a complete end-to-end revenue cycle management solution for HealthPac customers.
HyperBranch Medical Technology, Inc. announced today that it will begin to market their surgical sealants under a new product identity – Adherus Surgical Sealants.
Astellas Pharma Canada, Inc. announced today that Health Canada has approved VIBATIV(TM) (telavancin) for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus aureus, both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains.
Hospital ownership of physician groups increased patient care costs by as much as 20 percent, according to the UC Berkeley study. Meanwhile, another study by Harvard researchers finds that switching to for-profit status may boost hospitals' financial health but has no effect on quality of care.
› Verified 7 days ago
| Entity Name | The Miriam Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851677470 PECOS PAC ID: 6901796408 Enrollment ID: O20120416000473 |
News Archive
Regulus Therapeutics Inc. today announced that new data from its metabolic disease program were presented at the "Diabetes" Keystone Symposium held April 12-17 in Whistler, British Columbia. The new pre-clinical research findings showed that therapeutic oligonucleotides targeting microRNA are able to improve insulin resistance and normalize plasma glucose in mouse models of diabetes while having no significant effect on glucose or insulin levels in normal mice.
ClaimRemedi, a provider of claim lifecycle management solutions, announced recently that they have signed an agreement with HealthPac Computer Systems, Inc., a Savannah, GA based Practice Management and Medical Billing software company. Under the agreement, ClaimRemedi will provide a complete end-to-end revenue cycle management solution for HealthPac customers.
HyperBranch Medical Technology, Inc. announced today that it will begin to market their surgical sealants under a new product identity – Adherus Surgical Sealants.
Astellas Pharma Canada, Inc. announced today that Health Canada has approved VIBATIV(TM) (telavancin) for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus aureus, both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains.
Hospital ownership of physician groups increased patient care costs by as much as 20 percent, according to the UC Berkeley study. Meanwhile, another study by Harvard researchers finds that switching to for-profit status may boost hospitals' financial health but has no effect on quality of care.
› Verified 7 days ago
| Entity Name | Lifespan Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407116643 PECOS PAC ID: 2567455082 Enrollment ID: O20121029000368 |
News Archive
Regulus Therapeutics Inc. today announced that new data from its metabolic disease program were presented at the "Diabetes" Keystone Symposium held April 12-17 in Whistler, British Columbia. The new pre-clinical research findings showed that therapeutic oligonucleotides targeting microRNA are able to improve insulin resistance and normalize plasma glucose in mouse models of diabetes while having no significant effect on glucose or insulin levels in normal mice.
ClaimRemedi, a provider of claim lifecycle management solutions, announced recently that they have signed an agreement with HealthPac Computer Systems, Inc., a Savannah, GA based Practice Management and Medical Billing software company. Under the agreement, ClaimRemedi will provide a complete end-to-end revenue cycle management solution for HealthPac customers.
HyperBranch Medical Technology, Inc. announced today that it will begin to market their surgical sealants under a new product identity – Adherus Surgical Sealants.
Astellas Pharma Canada, Inc. announced today that Health Canada has approved VIBATIV(TM) (telavancin) for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus aureus, both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains.
Hospital ownership of physician groups increased patient care costs by as much as 20 percent, according to the UC Berkeley study. Meanwhile, another study by Harvard researchers finds that switching to for-profit status may boost hospitals' financial health but has no effect on quality of care.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wen-chih Hank Wu, MD 830 Chalkstone Ave, 111-a, Providence, RI 02908-4734 Ph: (401) 273-7100 | Wen-chih Hank Wu, MD 830 Chalkstone Ave, 111-a, Providence, RI 02908-4734 Ph: (401) 273-7100 |
News Archive
Regulus Therapeutics Inc. today announced that new data from its metabolic disease program were presented at the "Diabetes" Keystone Symposium held April 12-17 in Whistler, British Columbia. The new pre-clinical research findings showed that therapeutic oligonucleotides targeting microRNA are able to improve insulin resistance and normalize plasma glucose in mouse models of diabetes while having no significant effect on glucose or insulin levels in normal mice.
ClaimRemedi, a provider of claim lifecycle management solutions, announced recently that they have signed an agreement with HealthPac Computer Systems, Inc., a Savannah, GA based Practice Management and Medical Billing software company. Under the agreement, ClaimRemedi will provide a complete end-to-end revenue cycle management solution for HealthPac customers.
HyperBranch Medical Technology, Inc. announced today that it will begin to market their surgical sealants under a new product identity – Adherus Surgical Sealants.
Astellas Pharma Canada, Inc. announced today that Health Canada has approved VIBATIV(TM) (telavancin) for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus aureus, both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains.
Hospital ownership of physician groups increased patient care costs by as much as 20 percent, according to the UC Berkeley study. Meanwhile, another study by Harvard researchers finds that switching to for-profit status may boost hospitals' financial health but has no effect on quality of care.
› Verified 7 days ago
Christopher Donald Palmer, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 101 Dudley St, Providence, RI 02905 Phone: 401-274-1122 Fax: 401-453-7597 | |
Martha Catherine Trimbur, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 245 Chapman St Ste 300, Providence, RI 02905 Phone: 401-444-4741 Fax: 401-444-4445 | |
Karl Herman, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 164 Summit Ave, Fain Bldg., Providence, RI 02906 Phone: 401-793-4489 Fax: 401-793-4047 | |
Muhammad Baig, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 164 Summit Ave, Fain Bldg, Providence, RI 02906 Phone: 401-793-4489 Fax: 401-793-4047 | |
Dr. Peter Sidhom, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 825 Chalkstone Ave, Providence, RI 02908 Phone: 603-560-2276 | |
Dr. Kanhai Farrakhan, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-457-3336 Fax: 401-525-2349 | |
Gary M Katzman, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 208 Collyer Street, Suite 100, Providence, RI 02904 Phone: 401-793-7191 Fax: 401-793-7200 |